Cargando…

Progress in immunotherapy for small cell lung cancer

Small-cell lung cancer (SCLC) is a special type of lung cancer that belongs to highly aggressive neuroendocrine tumors. At present, radiotherapy and chemotherapy remain the mainstay of treatment for SCLC. Progress in targeted therapies for SCLC with driver mutations has been slow, and these therapie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Dong, Xie, Bing, Yang, Yong, Yan, Peng, Liang, Sheng-Nan, Lin, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450814/ https://www.ncbi.nlm.nih.gov/pubmed/32874950 http://dx.doi.org/10.5306/wjco.v11.i6.370

Ejemplares similares

Progress in image-guided radiotherapy for the treatment of non-small cell lung cancer
por: Ren, Xiao-Cang, et al.
Publicado: (2019)

Neoadjuvant treatment in non-small cell lung cancer: New perspectives with the incorporation of immunotherapy
por: Aguado, Carlos, et al.
Publicado: (2022)

Immunotherapy combinations and chemotherapy sparing schemes in first line non-small cell lung cancer
por: Sereno, María, et al.
Publicado: (2021)

Progress in treatment of small-cell lung cancer: role of CPT-11
por: Saijo, N
Publicado: (2003)

Combined targeted therapy and immunotherapy for cancer treatment
por: Guo, Cheng-Xiang, et al.
Publicado: (2021)

Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?
por: Remon, Jordi, et al.
Publicado: (2017)

Progress in immunotherapy for neuroendocrine neoplasm of the digestive system
por: Pan, Wei-Xuan, et al.
Publicado: (2023)

Neuronal characteristics of small-cell lung cancer
por: Onganer, P U, et al.
Publicado: (2005)

Research status on immunotherapy trials of gastric cancer
por: Liang, Chao, et al.
Publicado: (2021)

Immunotherapy for pancreatic cancer
por: Yoon, Jai Hoon, et al.
Publicado: (2021)

T-regulatory cell modulation: the future of cancer immunotherapy?
por: Nizar, S, et al.
Publicado: (2009)

Current treatment landscape for oligometastatic non-small cell lung cancer
por: Garde-Noguera, Javier, et al.
Publicado: (2022)

Immunotherapy for advanced gastric cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Antibiotics and immunotherapy in gastrointestinal tumors: Friend or foe?
por: Yan, Cong, et al.
Publicado: (2019)

Therapeutic challenge for immunotherapy targeting cold colorectal cancer: A narrative review
por: Ma, Shi-Xun, et al.
Publicado: (2023)

Targeting cytotoxic T lymphocytes for cancer immunotherapy
por: Maher, J, et al.
Publicado: (2004)

Artificial intelligence in gastric cancer: Application and future perspectives
por: Niu, Peng-Hui, et al.
Publicado: (2020)

Treatment options for small cell lung cancer – do we have more choice?
por: Puglisi, M, et al.
Publicado: (2010)

Stereotactic body radiation therapy for non-small cell lung cancer: A review
por: Prezzano, Kavitha M, et al.
Publicado: (2019)

Research progress of integrated traditional Chinese and Western medicine in the treatment of advanced gastric cancer
por: Ye, Hui-Nan, et al.
Publicado: (2023)

Role of urothelial cells in BCG immunotherapy for superficial bladder cancer
por: Bevers, R F M, et al.
Publicado: (2004)

iPSC-Derived Natural Killer Cells for Cancer Immunotherapy
por: Karagiannis, Peter, et al.
Publicado: (2021)

Review of epidermal growth factor receptor-tyrosine kinase inhibitors administration to non-small-cell lung cancer patients undergoing hemodialysis
por: Lan, Chou-Chin, et al.
Publicado: (2022)

Implication of gut microbiome in immunotherapy for colorectal cancer
por: Koustas, Evangelos, et al.
Publicado: (2022)

Progress of magnetic resonance imaging radiomics in preoperative lymph node diagnosis of esophageal cancer
por: Xu, Yan-Han, et al.
Publicado: (2023)

MicroRNA in lung cancer
por: Lin, P-Y, et al.
Publicado: (2010)

Metastasis-associated lung adenocarcinoma transcript 1 molecular mechanisms in gastric cancer progression
por: Batista, Daniel Mateus de Oliveira, et al.
Publicado: (2023)

Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma
por: Chen, Pu, et al.
Publicado: (2021)

Clinical Perspectives to Overcome Acquired Resistance to Anti–Programmed Death-1 and Anti–Programmed Death Ligand-1 Therapy in Non-Small Cell Lung Cancer
por: Lee, Yong Jun, et al.
Publicado: (2021)

Deep diving in the PACIFIC: Practical issues in stage III non-small cell lung cancer to avoid shipwreck
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2020)

Optimal timing of thoracic irradiation for limited stage small cell lung cancer: Current evidence and future prospects
por: Sager, Omer, et al.
Publicado: (2022)

Recent advances in triple negative breast cancer: the immunotherapy era
por: Marra, Antonio, et al.
Publicado: (2019)

Exploring the food-gut axis in immunotherapy response of cancer patients
por: Russo, Edda, et al.
Publicado: (2020)

Immunotherapy in biliary tract cancers: Current evidence and future perspectives
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2022)

Progress and prospect of stem cell therapy for diabetic erectile dysfunction
por: Luo, Dao-Sheng, et al.
Publicado: (2021)

Advances in immunotherapy for melanoma
por: Redman, Jason M., et al.
Publicado: (2016)

Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer
por: Pallis, A G, et al.
Publicado: (2011)

Immunotherapy in colorectal cancer: Available clinical evidence, challenges and novel approaches
por: Tintelnot, Joseph, et al.
Publicado: (2019)

Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations
por: Guo, Songchuan, et al.
Publicado: (2017)

Tsunami of immunotherapy reaches mesothelioma
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nvtso6pc9gkt9ii18uhtpf92qo